510(k) Report

510(k) · Cleared

Cleared

Pefakit Apc-R Factor V Leiden

K042762510(k) TraditionalCleared Dec 22, 200478-day reviewClass II21 CFR 864.7925

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pentapharm, Ltd. · GGW Test, Time, Partial Thromboplastin

Cleared on Dec 22, 2004 as substantially equivalent to K963111 (Chromogenix AB, 1996) after a 78-day review. Its family tree reaches back 2 generations to 1995.

Decided
Dec 22, 2004
Review
78 days
Class
Class II
Product code
GGW
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K945940 (1995). No later device cites it as a predicate yet.

  1. Root · 2 generations backK945940 Coatest (R) Apc (TM) ResistanceAxis-Shield Doc AS · 1995
  2. 1 generation backK963111 Coatest Apc (TM) Resistance V/Coatest Apc (TM) Resistance V SChromogenix AB · 1996
  3. This deviceK042762 Pefakit Apc-R Factor V LeidenPentapharm, Ltd. · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K945940Coatest (R) Apc (TM) ResistanceAxis-Shield Doc AS1995—
−1K963111Coatest Apc (TM) Resistance V/Coatest Apc (TM) Resistance V SChromogenix AB1996—
0 (this device)K042762Pefakit Apc-R Factor V LeidenPentapharm, Ltd.2004—
FIG. 1 — Lineage of K042762, 1995–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GGW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GGW device

  1. #1 K260551 HemosIL Factor V Leiden (APC Resistance V)score 11.3 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K963111Coatest Apc (TM) Resistance V/Coatest Apc (TM) Resistance V S
Summary page 1
…Predicate Device Name: COATEST'® APCTM RESISTANCE V/ COATES'rAPCTM RESISTANCE VS 510(k) Number: K963111 Regulation Number: 864.7925 Regulatory Class: II 4. Description of the dev…
Chromogenix AB1996—

Also cleared against K963111: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 3 companies; a new generation was cleared every 8.0 years on median.
  • None of the 2 ancestors has a recall.
  • 4 other devices also cite its predicate K963111.

How does its category compare?

All GGW devices

GGW Test, Time, Partial Thromboplastin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GGW

1in 2010

2009: 12010: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GGW

Too few GGW 510(k)s in any year since 2007 to give a median.

Recalls per year · GGW

1in 2011

2011: 1
2007high 1 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GGW

11in 2025

2012: 42013: 22014: 22016: 72017: 152018: 182019: 32020: 42021: 42022: 12024: 52025: 11
2007high 18 (2018) · low 0 (2007)2025

MAUDE reports naming product code GGW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20101—00
20110—10
20120—04
20130—02
20140—02
20150—00
20160—07
20170—015
20180—018
20190—03
20200—04
20210—04
20220—01
20230—00
20240—05
20250—011
20261—0—

What is it indicated for?

The device is a plasma based functional assay for the determination of resistance to activated protein C caused by the factor V Leiden mutation (FV:Q506) on automated and semi-automated blood coagulation analyzers using mechanical or optical detection principle.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K042762: Pefakit Apc-R Factor V Leiden.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K042762

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026